SCHEDULE 13G: Major Shareholder Discloses Over 56% Stake in Hong Kong Pharma Digital Technology Holdings
Beneficial Ownership Report
Lap Sun Wong and affiliated entities have disclosed beneficial ownership of 56.77% of Hong Kong Pharma Digital Technology Holdings Limited's Ordinary Shares.
Summary
- Lap Sun Wong, along with Fame Overseas Supply Chain Limited and Profit Seeker Limited (collectively, the "Reporting Persons"), has filed a Schedule 13G.
- As of March 31, 2025, the Reporting Persons beneficially owned an aggregate of 6,244,961 Ordinary Shares of Hong Kong Pharma Digital Technology Holdings Limited.
- This aggregate ownership represents 56.77% of the Issuer's outstanding Ordinary Shares, calculated based on 11,000,000 shares issued and outstanding as of March 31, 2025.
- Lap Sun Wong individually owns 1,710,180 Ordinary Shares.
- Fame Overseas Supply Chain Limited, where Lap Sun Wong is the sole director, owns 4,448,520 Ordinary Shares.
- Profit Seeker Limited, where Lap Sun Wong is the sole director and sole shareholder, owns 190,020 Ordinary Shares.
- Lap Sun Wong holds sole voting and dispositive power over all 6,244,961 beneficially owned shares.
Sentiment
Score: 5
Explanation: This document is a factual disclosure of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the company's operational or financial performance.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership, indicating a significant stake held by an individual and their affiliated entities in a publicly traded company. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: The disclosure of a majority stake (56.77%) by a single individual and their controlled entities indicates a concentrated ownership structure, which could impact corporate governance and strategic decision-making.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires the filing of this statement (beneficial ownership calculation date). |
| 06/03/2025 | Date the Schedule 13G statement was signed and filed. |
Keywords
Hong Kong Pharma Digital Technology Holdings Limited, Lap Sun Wong, Beneficial Ownership, Schedule 13G, Ordinary Shares, Shareholder, SEC Filing, Equity Stake, Control Person
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.